Insomnia
📧 Sign up to get email alerts when something new happens for Insomnia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-02-22Clinical Trial Update: Study of Eszopiclone Compared to Placebo in the Treatment of Insomnia Secondary to Perimenopause/Menopause [Phase 3]
A Phase 3 trial evaluating eszopiclone versus placebo for insomnia associated with perimenopause/menopause has completed.
-
CLINICAL_TRIALS trial_result · 2012-02-22Clinical Trial Update: Effects of One Evening Dose of 3 mg Eszopiclone on Next Day Driving Ability [Phase 3]
Phase 3 trial update assessing whether a single 3 mg evening dose of eszopiclone affects next-day driving ability in adults with primary ins…
-
CLINICAL_TRIALS trial_result · 2012-02-22Clinical Trial Update: 6-Month Chronic Efficacy & Safety Study of Eszopiclone in Adult Subjects With Primary Insomnia [Phase 3]
Phase 3, six-month study evaluating eszopiclone for primary insomnia has completed. The snippet does not include trial results.
-
CLINICAL_TRIALS trial_result · 2012-02-22Clinical Trial Update: Study of an Evening Dose of Eszopiclone on Next Day Driving Ability & Psychomotor/Memory Function in Healthy Volunteers [Phase 1]
Phase 1 trial evaluating an evening dose of eszopiclone on next-day driving ability and psychomotor/memory function in healthy volunteers; t…
-
CLINICAL_TRIALS trial_result · 2012-02-22Clinical Trial Update: A Study of Eszopiclone in Subjects With Insomnia Related to Major Depressive Disorder [Phase 3]
Phase 3 study of eszopiclone in insomnia related to major depressive disorder has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-02-22Clinical Trial Update: A Study of Eszopiclone Co-administered With Venlafaxine in Subjects With Major Depressive Disorder and Insomnia [Phase 3]
Phase 3 trial evaluating co-administration of eszopiclone with venlafaxine for major depressive disorder with insomnia has completed.
-
FDA approval · 2012-02-21FDA Approved: ROZEREM — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for ROZEREM (ramelteon) submitted by Takeda Pharmaceuticals America, Inc.
-
CLINICAL_TRIALS trial_result · 2012-02-17Clinical Trial Update: Insomnia and Daytime Function in Osteoarthritis [Phase 4]
Sanofi-sponsored Phase 4 trial evaluating insomnia and daytime function in people with osteoarthritis has completed.
-
CLINICAL_TRIALS trial_result · 2012-02-08Clinical Trial Update: Quetiapine Extended Release (XR) for the Treatment of Menopausal Depression [Phase 4]
Phase 4 trial update shows completed study evaluating quetiapine extended-release for menopausal depression, including major depressive diso…
-
CLINICAL_TRIALS trial_result · 2012-02-02Clinical Trial Update: Safety and Efficacy of Ramelteon in Adults With Chronic Insomnia [Phase 3]
Phase 3 trial update showing safety and efficacy of ramelteon for adults with chronic insomnia.
-
FDA approval · 2012-01-26FDA Approved: LUNESTA — Supplemental Application (Waylis Therapeutics LLC)
The FDA approved a supplemental application for LUNESTA (eszopiclone) from Waylis Therapeutics LLC.
-
CLINICAL_TRIALS trial_result · 2012-01-20Clinical Trial Update: A Study of Zolpidem Tartrate Sublingual Tablet in Adult Patients With Insomnia [Phase 3]
A Phase 3 trial of Zolpidem Tartrate Sublingual Tablet in adults with insomnia has completed and results were posted in January 2012.
-
CLINICAL_TRIALS trial_result · 2012-01-20Clinical Trial Update: Driving Performance After Middle of the Night Administration of 3.5 mg Zolpidem Tartrate Sublingual Tablet [Phase 1]
Phase 1 trial evaluating driving performance after middle-of-the-night administration of 3.5 mg zolpidem tartrate sublingual tablet in indiv…
-
CLINICAL_TRIALS trial_result · 2012-01-20Clinical Trial Update: A Study of Zolpidem Tartrate Sublingual Tablet in Adult Patients With Insomnia [Phase 3]
This document reports the completion of a Phase 3 trial evaluating zolpidem tartrate sublingual tablets for adult insomnia, with results pos…
-
CLINICAL_TRIALS trial_result · 2012-01-12Clinical Trial Update: Effectiveness of Internet Cognitive Behavioral Therapy Intervention for Treating Insomnia [Phase 1, Phase 2]
A completed Phase 1/Phase 2 trial evaluating the effectiveness of an internet-based cognitive behavioral therapy intervention for insomnia.
-
CLINICAL_TRIALS trial_result · 2011-12-22Clinical Trial Update: Effect of Activated Charcoal and Time of Dose on the Pharmacokinetics of LY2624803 in Healthy Subject [Phase 1]
A Phase 1 pharmacokinetic study in healthy subjects evaluated the impact of activated charcoal and dosing time on LY2624803; results were po…
-
CLINICAL_TRIALS research · 2011-11-24Clinical Trial Update: Follow-up of a Study Examining Sleep Management in United States Veterans [Phase 1, Phase 2]
This is an update on a sleep-management study for insomnia in U.S. veterans, spanning Phase 1 and Phase 2; the trial is completed.
-
CLINICAL_TRIALS trial_result · 2011-11-07Clinical Trial Update: Safety and Efficacy of Chronic Hypnotic Use
A completed clinical trial update evaluating the safety and efficacy of chronic hypnotic use in individuals with primary insomnia.
-
FDA approval · 2011-10-30FDA Approved: SILENOR — Supplemental Application (Currax Pharmaceuticals LLC)
FDA approved a supplemental NDA for Silenor (doxepin hydrochloride) by Currax Pharmaceuticals LLC. The approval relates to a change to the p…
-
CLINICAL_TRIALS trial_result · 2011-10-06Clinical Trial Update: A Study to Evaluate Efficacy and Safety of Zolpidem Modified Release Formulation in Insomnia Patients [Phase 4]
A Phase 4 study evaluating the efficacy and safety of a zolpidem modified-release formulation for insomnia has completed.
-
CLINICAL_TRIALS trial_result · 2011-09-16Clinical Trial Update: Internet-based Treatment for Chronic Insomnia [Phase 2]
Phase 2 clinical trial evaluating an internet-based treatment for chronic insomnia has completed and results have been posted. The study was…
-
FDA approval · 2011-09-13FDA Approved: ESZOPICLONE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved the original application for Eszopiclone (generic) by Lupin Pharmaceuticals, establishing a generic formulation for insomnia tr…
-
FDA approval · 2011-08-10FDA Approved: EDLUAR — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for EDLUAR (zolpidem tartrate) submitted by Viatris Specialty LLC.
-
CLINICAL_TRIALS trial_result · 2011-08-08Clinical Trial Update: Study to Investigate the Effects of Melatonin, Temazepam & Zolpidem on Sleep EEG in Men and Women [Phase 1]
Phase 1 study evaluating the effects of melatonin, temazepam, and zolpidem on sleep EEG in men and women with insomnia. The trial has comple…
-
FDA approval · 2011-08-04FDA Approved: ROZEREM — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for Rozerem (ramelteon) from Takeda Pharmaceuticals America, Inc.